136006-37-6

Basic information

• Product Name: (3R,5S)-6-<(p-tolylsulfonyl)oxy>-3,5-O-isopropylidene-3,5-dihydroxyhexanoic acid tert-butyl ester
• Synonyms: (3R,5S)-6-<(p-tolylsulfonyl)oxy>-3,5-O-isopropylidene-3,5-dihydroxyhexanoic acid tert-butyl ester
• CAS NO: 136006-37-6
• Molecular Weight: 414.52
• Mol File: 136006-37-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (3R,5S)-6-<(p-tolylsulfonyl)oxy>-3,5-O-isopropylidene-3,5-dihydroxyhexanoic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,5S)-6-<(p-tolylsulfonyl)oxy>-3,5-O-isopropylidene-3,5-dihydroxyhexanoic acid tert-butyl ester(136006-37-6)
• EPA Substance Registry System: (3R,5S)-6-<(p-tolylsulfonyl)oxy>-3,5-O-isopropylidene-3,5-dihydroxyhexanoic acid tert-butyl ester(136006-37-6)

Safety Data

• Hazardous Substances Data: 136006-37-6(Hazardous Substances Data)

Upstream product

• 124655-09-0 1,1-dimethylethyl (4R-cis)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate 
• 98-59-9 p-toluenesulfonyl chloride 
• 407577-54-2 (4R-cis)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester 
• 104-15-4 toluene-4-sulfonic acid 

Relevant articles and documents

Pitavastatin calcium intermediate preparation method

The invention discloses a pitavastatin calcium intermediate preparation method. The method includes steps: subjecting (4R-Cis)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethylethylester and paratoluensulfonyl chloride to sulfonylation r

2-Amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors

Novel compounds are provided which are glycogen phosphorylase inhibitors which are useful in treating, preventing or slowing the progression of diseases requiring glycogen phosphorylase inhibitor therapy such as diabetes and related conditions (such as hy

Synthesis and Biological activity of new HMG-CoA reductase inhibitors. 3.1,2 lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids

A group of 43 optically active sodium carboxylates (11a-qq and the corresponding lactones 4 were prepared from respective phenols 8 according to Schemes I-III. Phenols 8 were synthesized from commercially available compounds according to Schemes IV-IX. A